Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion

Cancer Research

Volumn 63, Issue 10, 2003, Pages 2561-2568

  Orsini, Enrica ^a   Bellucci, Roberto ^c   Alyea, Edwin P ^c   Schlossman, Robert ^c   Canning, Christine ^c   McLaughlin, Stephen ^c   Ghia, Paolo ^c   Anderson, Kenneth C ^c   Ritz, Jerome ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL TRANSFORMATION; DONOR LYMPHOCYTE INFUSION; EPSTEIN BARR VIRUS; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS MYELOMA EFFECT; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE TRANSFER; MALE; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION;

EID: 0037505840     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Kolb, H. J., Schattenberg, A., Goldman, J. M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood, 86: 2041-2050, 1995.
2. Lokhorst, H. M., Schattenberg, A., Cornelissen, J. J., Thomas, L. L., and Verdonck, L. F. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, 90: 4206-4211, 1997.
3. Lokhorst, H. M., Schattenberg, A., Cornelissen, J. J., van Oers, M. H., Fibbe, W., Russell, I., Donk, N. W., and Verdonck, L. F. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome. J. Clin. Oncol., 18: 3031-3037, 2000.
4. Alyea, E., Weller, E., Schlossman, R., Canning, C., Webb, I., Doss, D., Mauch, P., Marcus, K., Fisher, D., Freeman, A., Parikh, B., Gribben, J., Soiffer, R., Ritz, J., and Anderson, K. T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graftversus-myeloma effect. Blood, 98: 934-939, 2001.
5. Molldrem, J. J., Lee, P. P., Wang, C., Felio, K., Kantarjian, H. M., Champlin, R. E., and Davis, M. M. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat. Med., 6: 1018-1023, 2000.
6. Faber, L. M., van der Hoeven, J., Goulmy, E., Hooftman-den Otter, A. L., van Luxemburg-Heijs, S. A., Willemze, R., and Falkenburg, J. H. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. J. Clin. Investig., 96: 877-883, 1995.
7. Bonnet, D., Warren, E. H., Greenberg, P. D., Dick, J. E., and Riddell, S. R. CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc. Natl. Acad. Sci. USA. 96: 8639-8644, 1999.
8. Mutis, T., Blokland, E., Kester, M., Schrama, E., and Goulmy, E. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation. Blood, 100: 547-552, 2002.
9. Yang, Y. G., Sergio, J. J., Pearson, D. A., Szot, G. L., Shimizu, A., and Sykes, M. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood, 90: 4651-4660, 1997.
10. Anderson, L. D., Jr., Savary, C. A., and Mullen, C. A. Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease. Blood, 95: 2426-2433, 2000.
11. Tsukada, N., Kobata, T., Aizawa, Y., Yagita, H., and Okumura, K. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood, 93: 2738-2747, 1999.
12. Alyea, E. P., Soiffer, R. J., Canning, C., Neuberg, D., Schlossman, R., Pickett, C., Collins, H., Wang, Y., Anderson, K. C., and Ritz, J. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood, 91: 3671-3680, 1998.
13. Giralt, S., Hester, J., Huh, Y., Hirsch-Ginsberg, C., Rondon, G., Seong, D., Lee, M., Gajewski, J., Van Besien, K., Khouri, I., et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 86: 4337-4343, 1995.
14. Mackinnon, S., Papadopoulos, E. B., Carabasi, M. H., Reich, L., Collins, N. H., Boulad, F., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Keman, N. A., Small, T. N., Young, J. W., and O'Reilly, R. J. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86: 1261-1268, 1995.
15. Dazzi, F., Szydlo, R. M., Craddock, C., Cross, N. C., Kaeda, J., Chase, A., Olavarria, E., van Rhee, F., Kanfer, E., Apperley, J. F., and Goldman, J. M. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood. 95: 67-71, 2000.
16. Shimoni, A., Gajewski, J. A., Donato, M., Martin, T., O'Brien, S., Talpaz, M., Cohen, A., Korbling, M., Champlin, R., and Giralt, S. Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation. Biol. Blood Marrow Transplant., 7: 568-575, 2001.
17. Orsini, E., Alyea, E. P., Schlossman, R., Canning, C., Soiffer, R. J., Chillemi, A., Neuberg, D., Anderson, K. C., and Ritz, J. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion. Bone Marrow Transplant., 25: 623-632, 2000.
18. Claret, E. J., Alyea, E. P., Orsini, E., Pickett, C. C., Collins, H., Wang, Y., Neuberg, D., Soiffer, R. J., and Ritz, J. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J. Clin. Investig., 100: 855-866, 1997.
19. Bellucci, R., Alyea, E., Weller, E., Chillemi, A., Hochberg, E., Wu, C., Canning, C., Schlossman, R., Soiffer, R., Anderson, K., and Ritz, J. Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma. Blood, 99: 4610-4617, 2002.
20. Orsini, E., Alyea, E. P., Chillemi, A., Schlossman, R., McLaughlin, S., Canning, C., Soiffer, R. J., Anderson, K. C., and Ritz, J. Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma. Biol. Blood Marrow Transplant., 6: 375-386, 2000.
21. Wu, C. J., Chillemi, A., Alyea, E. P., Orsini, E., Neuberg, D., Soiffer, R. J., and Ritz, J. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood, 95: 352-359, 2000.
22. Pannetier, C., Cochet, M., Darche, S., Casrouge, A., Zoller, M., and Kourilsky, P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA, 90: 4319-4323, 1993.
23. Zorn, E., Orsini, E., Wu, C. J., Stein, B., Chillemi, A., Canning, C., Alyea, E. P., Soiffer, R. J., and Ritz, J. A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells. Transplantation, 71: 1131-1137, 2001.
24. Genevee, C., Diu, A., Nierat, J., Caignard, A., Dietrich, P. Y., Ferradini, L., Roman-Roman, S., Triebel, F., and Hercend, T. An experimentally validated panel of subfamily-specific oligonucleotide primers (V α 1-w29/V β 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol., 22: 1261-1269, 1992.
25. Sourdive, D. J., Murali-Krishna, K., Altman, J. D., Zajac, A. J., Whitmire, J. K., Pannetier, C., Kourilsky, P., Evavold, B., Sette, A., and Ahmed, R. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med., 188: 71-82, 1998.
26. Dietrich, P. Y., Caignard, A., Lim, A., Chung, V., Pico, J. L., Pannetier, C., Kourilsky, P., Hercend, T., Even, J., and Triebel, F. In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood, 84: 2815-2820, 1994.
27. Silins, S. L., Cross, S. M., Krauer, K. G., Moss, D. J., Schmidt, C. W., and Misko, I. S. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J. Clin. Investig., 102: 1551-1558, 1998.
28. Hochberg, E. P., Chillemi, A. C., Wu, C. J., Neuberg, D., Canning, C., Hartman, K., Alyea, E. P., Soiffer, R. J., Kalams, S. A., and Ritz, J. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood, 98: 1116-1121, 2001.
29. den Haan, J. M., Sherman, N. E., Blokland, E., Huczko, E., Koning, F., Drijthout, J. W., Skipper, J., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science, 268: 1476-1480, 1995.
30. Brickner, A. G., Warren, E, H., Caldwell, J. A., Akatsuka, Y., Golovina, T. N., Zarling, A. L., Shabanowitz, J., Eisenlohr, L. C., Hunt, D. F., Engelhard, V. H., and Riddell, S. R. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J. Exp. Med., 193: 195-206, 2001.
31. Warren, E. H., Gavin, M. A., Simpson, E., Chandler, P., Page, D. C., Disteche, C., Stankey, K. A., Greenberg, P. D., and Riddell, S. R. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J. Immunol., 164: 2807-2814, 2000.
32. Vogt, M. H., van den Muijsenberg, J. W., Goulmy, E., Spierings, E., Kluck, P., Kester, M. G., van Soest, R. A., Drijfhout, J. W., Willemze, R., and Falkenburg, J. H. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood, 99: 3027-3032, 2002.
33. Roux, E., Dumont-Girard, F., Starobinski, M., Siegrist, C. A., Helg, C., Chapuis, B., and Roosnek, E. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood, 96: 2299-2303, 2000.
34. Weinberg, K., Blazar, B. R., Wagner, J. E., Agura, E., Hill, B. J., Smogorzewska, M., Koup, R. A., Betts. M. R., Collins, R. H., and Douek, D. C. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood, 97: 1458-1466, 2001.
35. Douek, D. C., Vescio, R. A., Betts, M. R., Brenchley, J. M., Hill, B. J., Zhang, L., Berenson, J. R., Collins, R. H., and Koup, R. A. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet. 355: 1875-1881, 2000.
36. Mackall, C. L., Fry, T. J., Bare, C., Morgan, P., Galbraith, A., and Gress, R. E. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood, 97: 1491-1497, 2001.
37. Keever, C. A., Small, T. N., Flomenberg, N., Heller, G., Pekle, K., Black, P., Pecora, A., Gillio, A., Kernan, N. A., and O'Reilly, R. J. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood. 73: 1340-1350, 1989.
38. Soiffer, R. J., Bosserman, L., Murray, C., Cochran, K., Daley, J., and Ritz, J. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation. Blood, 75: 2076-2084, 1990.
39. Sugita, K., Nojima, Y., Tachibana, K., Soiffer, R. J., Murray, C., Schlossman, S. F., Ritz, J., and Morimoto, C. Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation. J. Clin. Investig., 94: 481-488, 1994.
40. Sato, T., Ohashi, Y., Tachibana, K., Soiffer, R. J., Ritz, J., and Morimoto, C. Altered tyrosine phosphorylation via the very late antigen (VLA)/β1 integrin stimulation is associated with impaired T-cell signaling through VLA-4 after allogeneic bone marrow transplantation. Blood, 90: 4222-4229, 1997.
41. Lin, M. T., Tseng, L. H., Frangoul, H., Gooley, T., Pei, J., Barsoukov, A., Akatsuka, Y., and Hansen, J. A. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood, 95: 3832-3839, 2000.
42. Davison, G. M., Novitzky, N., Kline, A., Thomas, V., Abrahams, L., Hale, G., and Waldmann, H. Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells. Transplantation, 69: 1341-1347, 2000.
43. Matloubian, M., Concepcion, R. J., and Ahmed, R. CD4+ T cells are required to sustain CDS+ cytotoxic T-cell responses during chronic viral infection. J. Virol., 68: 8056-8063, 1994.
44. Marzo, A. L., Kinnear, B. F., Lake, R. A., Frelinger, J. J., Collins, E. J., Robinson, B. W., and Scott, B. Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity. J. Immunol., 165: 6047-6055, 2000.
45. Surman, D. R., Dudley, M. E., Overwijk, W. W., and Restifo, N. P. CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen. J. Immunol., 164: 562-565, 2000.
46. Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D., and Ahmed, R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med., 188: 2205-2213, 1998.
47. Zorn, E., Wang, K. S., Hochberg, E. P., Canning, C., Alyea, E. P., Soiffer, R. J., and Ritz, J. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin. Cancer Res., 8: 2052-2060, 2002.
48. Halapi, E., Werner, A., Wahlstrom, J., Osterborg, A., Jeddi-Tehrani, M., Yi, Q., Janson, C. H., Wigzell, H., Grunewald, J., and Mellstedt, H. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden. Eur. J. Immunol., 27: 2245-2252, 1997.
49. Sze, D. M., Giesajtis, G., Brown, R. D., Raitakari, M., Gibson, J., Ho, J., Baxter, A. G., Fazekas de St Groth, B., Basten, A., and Joshua, D. E. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood, 98: 2817-2827, 2001.
50. Kay, N., Leong, T., Kyle, R. A., Greipp, P., Van Ness, B., Bone, N., and Oken, M. M. Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487). Leuk. Lymphoma, 33: 127-133, 1999.
51. Dianzani, U., Pileri, A., Boccadoro, M., Palumbo, A., Pioppo, P., Bianchi, A., Camponi, A., Fossati, G., Battaglio, S., and Massaia, M. Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood, 72: 1064-1068, 1988.
52. Yi, Q., Eriksson, I., He, W., Holm, G., Mellstedt, H., and Osterborg, A. Idiotype-specific T lymphocytes in monoclonal gammopathies: evidence for the presence of CD4+ and CD8+ subsets. Br. J. Haematol., 96: 338-345, 1997.
53. Li, Y., Bendandi, M., Deng, Y., Dunbar, C., Munshi, N., Jagannath, S., Kwak, L. W., and Lyerly, H. K. Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells. Blood, 96: 2828-2833, 2000.
54. Wen, Y. J., Barlogie, B., and Yi, Q. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells. Blood, 97: 1750-1755, 2001.